New drug shows promise for motor neurone disease treatment

A pioneering study published in the International Journal of Molecular Sciences by researchers at Durham University has revealed promising results for a new treatment targeting motor neurone disease (MND).

D.C. Diagnosis: Could RFK Jr. go ‘wild’ on health and medicine?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

October 29, 2024

PhRMA, top Democrats urge Supreme Court to take up abortion pill case

It’s a rarity these days to see the top pharma industry lobbying group join Senate and House Democrat leaders and argue the same side of

October 17, 2023

Updated: Venture capital firm General Catalyst is buying an Ohio-based health system

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) It’s official: General Catalyst is about to

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.